Avita Medical | 1811094D - 贷款资金

股票价格
1.10
每天变化
0.02 1.86%
每月一次
-19.78%
每年
-58.05%
Q2 预测
1.07


金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 144.19M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


贷款资金 更改 日
Accuray USD 127.32M 3.53M 2025-09
Celltrion KRW 63.29B 4.01B 2025-09
Clinuvel Pharmaceuticals AUD 17.25K 80.1K 2025-12
Cochlear AUD 200M 6.5M 2025-12
CSL USD 10.42B 273M 2025-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Mayne Pharma AUD 2.66M 153K 2025-06
Medical Developments International AUD 1.5M 167K 2025-12
Nanosonics AUD 3.21M 1.06M 2025-12
Organigram Holdings CAD 62.52M 13.88M 2025-12
Ovoca Bio EUR 0 0 2021-06
Pacific Edge NZD 551K 637K 2025-12
Paradigm Biopharmaceuticals AUD 436.81K 336.81K 2025-12
Pharma Mar EUR 36.68M 1.07M 2025-12
Polynovo AUD 15.39M 663K 2025-12
PYC Therapeutics AUD 436.93K 188.06K 2025-12
Qiagen NV USD 1.65B 15.23M 2025-12
Ramsay Health Care AUD 11.2B 5.74B 2025-12
ResMed USD 403.92M 4.74M 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Telix Pharmaceuticals AUD 448.45M 76.97M 2025-12
Tilray USD 268.59M 3.82M 2025-09
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 186.56M 9.75M 2025-09